Treating Cancer-Related Anxiety with Psychedelic Mushrooms

the MPR take:

Psilocybin, a Schedule I controlled substance, is being studied as a potential treatment for cancer-related anxiety. At NYU, Dr. Stephen Ross has been experimenting with this hallucinogenic, administering the drug to cancer patients and analyzing its effects. Data from the study show a reduction in anxiety that is immediate and sustained with 3/4 of patients rating the experience as being one of the most significant events in their lives. Unlike benzodiazepines, which only offer temporary anxiety relief, patients report enduring effects with psilocybin, even with just one dose.  Further analysis still needs to be done to see if psilocybin will be accepted as an approved therapy. At this time, given its status with the DEA, the drug is still considered to have no accepted medical use and carries high abuse potential.

Depression and anxiety decreased for cancer patients who took one dose of psilocybin
Depression and anxiety decreased for cancer patients who took one dose of psilocybin
A New York University research team is using hallucinogenic experiences to help patients come to terms with their mortality. He had the far-off look in his eyes that I recognized from so many of the other study participants. Ineffability is one of the primary criteria that define a mystical ...

READ FULL ARTICLE From The Atlantic

Loading links....